Gujarat Themis Biosyn Limited (GUJTHEM) — regulation 31

· NSE Neutral
📢 Key Event
Indirect encumbrance created on PBGIL's GTBL stake via pledge and non-disposal undertaking
🔄 What Changed
5,12,40,000 shares now under indirect encumbrance
💡 Investor Takeaway
This encumbrance may restrict PBGIL's ability to sell or transfer its GTBL shares without trustee approval.

Pharmaceutical Business Group (India) Limited disclosed an indirect encumbrance on its 47.02% stake in Gujarat Themis Biosyn Limited after Vividhmargi Investments created a pledge over 25,24,245 shares and a non-disposal undertaking over 21,57,855 shares of PBGIL on June 29, 2026, resulting in an indirect encumbrance on 5,12,40,000 shares held by PBGIL.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Limited (GUJTHEM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,034.98 Cr P/E: 84.4

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day